ACADIA Pharmaceuticals Inc (NASDAQ:ACAD)

40.10
Delayed Data
As of May 26
 -0.45 / -1.11%
Today’s Change
19.21
Today|||52-Week Range
46.48
+26.30%
Year-to-Date

Today’s Trading

Previous close40.55
Today’s open40.47
Day’s range39.74 - 40.99
Volume1,047,092
Average volume (3 months)2,091,007
Market cap$4.1B
Dividend yield--
Data as of 05/26/2015

Growth & Valuation

Earnings growth (last year)-115.91%
Earnings growth (this year)-41.99%
Earnings growth (next 5 years)--
Revenue growth (last year)-89.52%
P/E ratioNM
Price/Sales25,730.20
Price/Book13.11

Competitors

 Today’s
change
Today’s
% change
GRFSGrifols SA-0.80-2.43%
NBIXNeurocrine Bioscienc...-0.25-0.59%
IPXLImpax Laboratories I...-0.93-2.01%
HZNPHorizon Pharma PLC-0.15-0.47%
Data as of 05/26/2015

Financials

Next reporting dateAugust 4, 2015
EPS forecast (this quarter)-$0.32
Annual revenue (last year)$120.0K
Annual profit (last year)-$92.5M
Net profit margin-77,062.50%

Profile

Sector
Health Technology
Industry
Biotechnology
CEO, CFO, Chief Business Officer &
Executive VP
Stephen R. Davis
Chief Medical Officer &
Executive VP-Development
Roger G. Mills
Corporate headquarters
San Diego, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers